Biotest AG: Increase in sales and earnings in financial year 2006 higher than expected
Biotest AG / Preliminary Results
Ad hoc announcement according to § 15 WpHG transmitted by DGAP - a company
of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
----------------------------------------------------------------------
Increase in sales and earnings in financial year 2006 higher than expected
Dreieich, 14 February 2007. According to unaudited figures, Biotest Group
sales were 18.7% up on the previous year (EUR 237.6 million) to EUR 281.9
million. At EUR 31.4 million, earnings before interest and taxes (EBIT)
were 24.1% higher than in financial year 2005 (EUR 25.3 million), with an
improvement in profit before tax from EUR 15.0 million to EUR 21.6 million
(+43.9%). Group net profit excluding minority interests rose by 57.3% to
EUR 16.0 million (previous year: EUR 10.2 million) to generate earnings per
share amounting to EUR 1.48 (previous year: EUR 1.13). Consequently, growth
has surpassed the expectations of the Management.In the Pharmaceutical
segment, sales rose 27.9% to EUR 205.1 million (previous year: EUR 160.4
million), and in the Diagnostic segment, sales fell slightly to EUR 76.8
million (previous year: EUR 77.2 million).In spite of the significant
increase in the level of research and development costs, the operating
margin before interest and taxes rose from 10.6% to 11.1%. To a large
extent, the improvement in the results is attributable to the success of
the plasma protein business, while the Diagnostic segment closed with
slightly negative EBIT.
Biotest AG, Landsteinerstr. 5, D-63303 Dreieich, www.biotest.de
Dr. Michael Ramroth, Telefon: +49 (0) 6103 801-338, E-Mail:
michael_ramroth@biotest.de
Dr. Marion Wendorff, Telefon: +49 (0) 6103 801-520, E-Mail:
marion_wendorff@biotest.de
Telefax: +49 (0) 6103 801-347
DGAP 14.02.2007
----------------------------------------------------------------------
Language: English
Issuer: Biotest AG
Landsteinerstr. 5
63303 Dreieich Deutschland
Phone: +49 - 6103 / 801 - 0
Fax: +49 - 6103 / 801 - 150
E-mail: mail@biotest.de
WWW: www.biotest.de
ISIN: DE0005227201, DE0005227235
WKN: 522720, 522723
Indices:
Listed: Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in
Berlin-Bremen, Düsseldorf, Hamburg, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------------
